LDLRAP1
Low density lipoprotein receptor adapter protein 1
Also known as: ARH, ARH_HUMAN, ARH2, DKFZp586D0624, FHCB1, FHCB2, MGC34705
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5SW96
- Gene
- LDLRAP1
- Ensembl
- ENSG00000157978
- Chromosome
- 1
- Canonical length
- 308 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Microtubules
OverviewNCBI Gene
The protein encoded by this gene is a cytosolic protein which contains a phosphotyrosine binding (PTD) domain. The PTD domain has been found to interact with the cytoplasmic tail of the LDL receptor. Mutations in this gene lead to LDL receptor malfunction and cause the disorder autosomal recessive hypercholesterolaemia. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
308 residues, UniProt reviewed canonical sequence.
>Q5SW96|LDLRAP1
1 MDALKSAGRA LIRSPSLAKQ SWGGGGRHRK LPENWTDTRE TLLEGMLFSL KYLGMTLVEQ
61 PKGEELSAAA IKRIVATAKA SGKKLQKVTL KVSPRGIILT DNLTNQLIEN VSIYRISYCT
121 ADKMHDKVFA YIAQSQHNQS LECHAFLCTK RKMAQAVTLT VAQAFKVAFE FWQVSKEEKE
181 KRDKASQEGG DVLGARQDCT PSLKSLVATG NLLDLEETAK APLSTVSANT TNMDEVPRPQ
241 ALSGSSVVWE LDDGLDEAFS RLAQSRTNPQ VLDTGLTAQD MHYAQCLSPV DWDKPDSSGT
301 EQDDLFSFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LDLRAP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 80 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 80 nTPM
- spinal cord: 63 nTPM
- spleen: 56 nTPM
- pancreas: 37 nTPM
- lymph node: 35 nTPM
- salivary gland: 29 nTPM
Single-cell type
- platelets: 537 nCPM
- megakaryocytes: 87 nCPM
- oligodendrocytes: 69 nCPM
- respiratory basal cells: 61 nCPM
- choroid plexus epithelial cells: 57 nCPM
- salivary duct cells: 52 nCPM
Immune cell
- naive CD4 T-cell: 108 nTPM
- naive CD8 T-cell: 90 nTPM
- memory CD4 T-cell: 55 nTPM
- total PBMC: 51 nTPM
- T-reg: 50 nTPM
- memory CD8 T-cell: 43 nTPM
Brain region
- white matter: 60 nTPM
- medulla oblongata: 47 nTPM
- cerebellum: 41 nTPM
- pons: 38 nTPM
- choroid plexus: 36 nTPM
- midbrain: 34 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about LDLRAP1.
Disease | AllUniProt
Conditions LDLRAP1 is implicated in, by any mechanism.
- Hypercholesterolemia, familial, 4 (FHCL4) MIM:603813
Disease | GeneticClinVar
70 pathogenic / likely-pathogenic of 675 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hypercholesterolemia, familial, 4
- Familial hypercholesterolemia
- Cardiovascular phenotype
- Autosomal recessive inheritance
- See cases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.16
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.2
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- amyloid precursor protein metabolic process
- cellular response to cytokine stimulus
- cholesterol homeostasis
- cholesterol metabolic process
- cholesterol transport
- low-density lipoprotein particle clearance
- positive regulation of cholesterol metabolic process
- positive regulation of low-density lipoprotein particle clearance
- positive regulation of receptor-mediated endocytosis
- positive regulation of receptor-mediated endocytosis involved in cholesterol transport
- positive regulation of vascular associated smooth muscle cell proliferation
- receptor internalization
- receptor-mediated endocytosis
- receptor-mediated endocytosis involved in cholesterol transport
- regulation of protein binding
- regulation of protein localization to plasma membrane
Molecular functions
- amyloid-beta binding
- AP-1 adaptor complex binding
- AP-2 adaptor complex binding
- clathrin adaptor activity
- clathrin binding
- low-density lipoprotein particle receptor binding
- phosphatidylinositol-4,5-bisphosphate binding
- phosphotyrosine residue binding
- signaling adaptor activity
- signaling receptor complex adaptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LDLRAP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LDLRAP1 as an antibody target. Whether an autoantibody or antibody against LDLRAP1 could matter depends on whether native LDLRAP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LDLRAP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LDLRAP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...